ATELLICA TM IM CA 19-9
Mexico·Clase II·III. DIAGNOSTIC AGENTS·SIEMENS HEALTHCARE DIAGNOSTICS, S. DE R.L DE C.V.·Registered June 04, 2018EL ENSAYO ATELLICA™ IM CA 19-9 ESTÁ PREVISTO PARA USO DIAGNÓSTICO IN VITRO PARA LA DETERMINACIÓN CUANTITATIVA EN SERIE DE CA 19-9 EN SUERO HUMANO. EL ATELLICA™ IM CA 19-9 DIL ES UN DILUYENTE PARA USO DIAGNÓSTICO IN VITRO. AGENTE DE DIAGNÓSTICO. PARA USO
THE ATELLICA™ IM CA 19-9 ASSAY IS INTENDED FOR IN VITRO DIAGNOSTIC USE FOR THE SERIAL QUANTITATIVE DETERMINATION OF CA 19-9 IN HUMAN SERUM. ATELLICA™ IM CA 19-9 DIL IS A DILUENT FOR IN VITRO DIAGNOSTIC USE. DIAGNOSTIC AGENT. FOR USE
- Risk Class / Clase de Riesgo
- Clase II
- Product Type (Spanish)
- III. AGENTES DE DIAGNÓSTICO
- Product Type (English)
- III. DIAGNOSTIC AGENTS
- Trade Name (Spanish)
- ENSAYO PARA LA DETERMINACIÓN DE CA 19-9
- Trade Name (English)
- TEST FOR THE DETERMINATION OF CA 19-9
- Analysis ID
- 1329R2018 SSA
- Registration Date
- June 04, 2018
- Name (Spanish)
- SIEMENS HEALTHCARE DIAGNOSTICS, S. DE R.L DE C.V.
- Name (English)
- SIEMENS HEALTHCARE DIAGNOSTICS, S. DE R.L DE C.V.
Access comprehensive regulatory information for ATELLICA TM IM CA 19-9 (ATELLICA TM IM CA 19-9) in the Mexico medical device market through Pure Global AI's free database. This Clase II medical device is registered under COFEPRIS analysis ID 1329R2018 SSA and manufactured by SIEMENS HEALTHCARE DIAGNOSTICS, S. DE R.L DE C.V.. The device was registered on June 04, 2018.
This page provides complete registration details including product type (III. DIAGNOSTIC AGENTS), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.